{"transactions":[{"id":918397,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock option (right to buy)","published_at":"2026-02-05T21:50:05.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":4800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of the Issuer's common stock par value $0.0001 per share, pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":4800000,"derivative":{"exercise_price":4.45,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":4800000},"source":{"system":"sec-edgar","filing":"0001193125-26-039564","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312526039564/ownership.xml","form_type":"4"}},{"id":1054162,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & EXECUTIVE CHAIRMAN"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-28T21:15:05.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":4800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of the Issuer's common stock par value $0.0001 per share (\"Common Stock\"), pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended (the \"Plan\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The awards are subject to the Company's receipt of stockholder approval to amend the Plan, to increase the number of shares of Common Stock available for issuance thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the option vest over a four-year period, vesting 1/4 on March 1, 2026, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":4800000,"derivative":{"exercise_price":2.17,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":4800000},"source":{"system":"sec-edgar","filing":"0000950170-25-112077","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017025112077/ownership.xml","form_type":"4"}},{"id":1453197,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & EXECUTIVE CHAIRMAN"}}],"security":"Stock Option (right to buy)","published_at":"2024-07-17T20:30:05.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":35700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents a one-time grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest 25% on July 15, 2025, and in equal monthly installments thereafter over a three-year period ending July 15, 2028."},{"field":"security","element":"securityTitle","label":"F2","text":"This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a one-time grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest 25% on July 15, 2025, and in equal monthly installments thereafter over a three-year period ending July 15, 2028."}],"balance_after":35700,"derivative":{"exercise_price":2.9,"expiration_date":"2034-07-15","underlying":"Common Stock","underlying_shares":35700},"source":{"system":"sec-edgar","filing":"0000950170-24-084295","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017024084295/ownership.xml","form_type":"4"}},{"id":1623694,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & EXECUTIVE CHAIRMAN"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-23T21:40:16.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":434000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":434000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":434000},"source":{"system":"sec-edgar","filing":"0000950170-24-019430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017024019430/ownership.xml","form_type":"4"}},{"id":1727276,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-11-30T13:00:04.000Z","date":"2023-11-29","kind":"purchase","planned":false,"acquired":true,"shares":11000,"price":0.8947,"value":9841.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 11,000 shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), acquired by the reporting person in an open market transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,000 shares of Common Stock held jointly by the reporting person and the reporting person's spouse."}],"balance_after":219001,"source":{"system":"sec-edgar","filing":"0000950170-23-066901","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017023066901/ownership.xml","form_type":"4"}},{"id":1951147,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-16T20:28:42.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":525000,"derivative":{"exercise_price":0.54,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001437749-23-006910","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000143774923006910/rdgdoc.xml","form_type":"4"}},{"id":1981707,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Warrants","published_at":"2023-03-02T14:18:12.000Z","date":"2023-02-28","kind":"other","acquired":true,"shares":9968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person received 9,968 warrants as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person received 9,968 warrants as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis."}],"balance_after":9968,"derivative":{"exercise_price":11.5,"exercise_date":"2022-01-14","expiration_date":"2026-10-20","underlying":"Common Stock","underlying_shares":9968},"source":{"system":"sec-edgar","filing":"0001437749-23-005165","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000143774923005165/rdgdoc.xml","form_type":"4"}},{"id":1981706,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Warrants","published_at":"2023-03-02T14:18:12.000Z","date":"2023-02-28","kind":"other","acquired":false,"shares":208600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Via Big Cypress Holdings LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution received 9,968 warrants of the issuer, which the Reporting Person previously had an indirect pecuniary interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution received 9,968 warrants of the issuer, which the Reporting Person previously had an indirect pecuniary interest."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2022-01-14","expiration_date":"2026-10-20","underlying":"Common Stock","underlying_shares":208600},"source":{"system":"sec-edgar","filing":"0001437749-23-005165","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000143774923005165/rdgdoc.xml","form_type":"4"}},{"id":2158880,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-15T21:15:15.000Z","date":"2022-09-13","kind":"grant","acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining\n3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":525000,"derivative":{"exercise_price":0.71,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001209191-22-050106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000120919122050106/doc4.xml","form_type":"4"}},{"id":2260906,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-05-23T21:45:16.000Z","date":"2022-05-20","kind":"other","acquired":true,"shares":207001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person received 207,001 shares as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest.  Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13.  Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person received 207,001 shares as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest.  Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13.  Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis."}],"balance_after":208001,"source":{"system":"sec-edgar","filing":"0001209191-22-031398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000120919122031398/doc4.xml","form_type":"4"}},{"id":2260905,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-05-23T21:45:16.000Z","date":"2022-05-20","kind":"other","acquired":false,"shares":2500127,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Via Big Cypress Holdings LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution.  The Reporting  Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution will receive 207,001 shares of the issuer, which the Reporting Person previously had an indirect pecuniary interest."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution.  The Reporting  Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution will receive 207,001 shares of the issuer, which the Reporting Person previously had an indirect pecuniary interest."}],"balance_after":547698,"source":{"system":"sec-edgar","filing":"0001209191-22-031398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000120919122031398/doc4.xml","form_type":"4"}},{"id":2325546,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-19T01:15:39.000Z","date":"2022-03-16","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option will vest in full on the one-year anniversary of March 16, 2022, the date the award was approved by the Company's board of directors."}],"balance_after":7000,"derivative":{"exercise_price":1.78,"expiration_date":"2032-03-16","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-22-011663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000089924322011663/doc4.xml","form_type":"4"}},{"id":2503720,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-19T21:05:49.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted to the Reporting Person pursuant to the Company's 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a three-year period, vesting 1/3 on the one-year anniversary of the date of grant, and the remaining 2/3 vesting pro rata on a monthly basis in 24 equal installments thereafter."}],"balance_after":350000,"derivative":{"exercise_price":11.17,"expiration_date":"2031-11-17","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-21-029370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000149315221029370/ownership.xml","form_type":"4"}},{"id":2542001,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2021-10-15T14:48:42.000Z","date":"2021-10-14","kind":"purchase","acquired":true,"shares":1000,"price":10.11,"value":10110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 1,000 shares of the issuer's common stock acquired jointly by the reporting person and the reporting person's spouse in open market transactions."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents 1,000 shares of the issuer's common stock acquired jointly by the reporting person and the reporting person's spouse in open market transactions."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001493152-21-025508","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000149315221025508/ownership.xml","form_type":"4"}},{"id":2907659,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67623,"kind":"person","name":"Reich Samuel J","position":1,"cik":"0001394645","reported_name":"Reich Samuel J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and CFO"}}],"security":"Common Stock","published_at":"2021-01-14T18:33:47.000Z","date":"2021-01-14","kind":"purchase","acquired":true,"shares":417200,"price":10,"value":4172000.0,"ownership":{"direct":false,"nature":"Via Big Cypress Holdings LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares are included within the 417,200 private placement units of the issuer purchased by Big Cypress Holdings LLC (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the issuer's initial public offering, and each such unit consists of one share of common stock of the issuer and one-half of one warrant of the issuer. The warrants included in the units will become exercisable, if at all, on the later of 30 days after the completion of the issuer's initial business combination and 12 months from the closing of the issuer' initial public offering. The securities are held directly by the Sponsor and indirectly by Samuel J. Reich and Ilan Katz as managers of the Sponsor."}],"balance_after":3047825,"source":{"system":"sec-edgar","filing":"0001493152-21-001030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000149315221001030/ownership.xml","form_type":"4"}}]}